Resources | NITAG RESOURCE CENTER

2022 ∙ SAGE

Should an off-label , permissive one-dose HPV vaccine schedule for use in routine and/or multi-age cohort (MAC) catch up strategies be recommended?

2022 ∙ SAGE

Human papillomavirus vaccines: WHO position paper, December 2022

2022

Introduction of Hepatitis B Birth Dose Vaccination in Africa: A Toolkit for National Immunization Technical Advisory Groups

2022 ∙ TITAG

Recommendation on nOPV2 vaccine

2022 ∙ TITAG

Introduction of malaria vaccine RTS,S/AS01 for use among children in Tanzania populace

2022 ∙ NACI

Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration

2022 ∙ ACIP

Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

2022 ∙ ACIP

Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

2022 ∙ ACIP

Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

2022 ∙ ACIP

Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022